Molecular Analysis of Latent Membrane Protein 1 in Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Japan

References

• Kieff E. Epstein-Barr virus and its replication. Virology, 3rd edn, B. N. Fields, D. M. Knipe, P. M. Howley. Lippincott-Raven Publishers, Philadelphia 1996; Vol. 2: 2343–2396
   Google Scholar
• Su I. J., Chen J. Y. The role of Epstein-Barr virus in lymphoid malignancies. Critical Reviews in Oncology/Hematology 1997; 26: 25–41
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I., Hummel M., Stein H. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Leukemia & Lymphoma 1995; 19: 1–12
   PubMed Web of Science ®Google Scholar
• Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. New England Journal of Medicine 1998; 338: 1413–1421
   PubMed Web of Science ®Google Scholar
• Hu L. F., Zabarovsky E. R., Chen R., Cao S. L., Ernberg I., Klein G., Winberg G. Isolation and sequence of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. Journal of General Virology 1991; 72: 2399–2409
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Brousset P., Rothenberger S., Einsele H., Lestou V S., Delsol G., Bachmann R., Ambros P. F., Odermatt B. R. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995; 10: 523–528
   PubMed Web of Science ®Google Scholar
• Kingma D. W., Weiss W. B., Jaffe E. S., Kumar S., Frekko K., Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Henter J. I., Elinder G., Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Seminar in Oncology 1991; 18: 29–33
   PubMed Web of Science ®Google Scholar
• Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. International Journal of Hematology 1997; 66: 135–151
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Morinaga S., Takagi K., Chen J., Mugishima H., Ishii T., Sako M., Arakawa H., Kato M. Haemophagocytic lymphohistiocytosis in association with granular lymphocyte proliferative disorders in early childhood: characteristic bone marrow morphology. British Journal of Haematology 1997; 96: 708–714
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. Journal of Pediatrics 1997; 130: 352–357
   PubMed Web of Science ®Google Scholar
• Yao M., Cheng A. L., Su I. J., Lin M. T., Uen W. C., Tien H. F., Wang C. H., Chen Y. C. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. British Journal of Haematology 1994; 87: 535–43
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Tabata Y., Sako M., Sekine Y., Hirayama K., Sakazaki H., Maeda N., Kito H., Shichino H., Mugishima H. Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Medical and Pediatric Oncology 1998; 31: 131–137
   PubMedGoogle Scholar
• Kawaguchi H., Miyashita T., Herbst H., Niedobitek G., Asada M., Tsuchida M., Hanada R., Kinoshita A., Sakurai M., Kobayashi N., Mizutani S. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. Journal of Clinical Investigation 1993; 92: 1444–1450
   PubMed Web of Science ®Google Scholar
• Teshima T., Miyaji R., Fukuda M., Ohshima K. Bone-marrow transplantation for Epstein-Barr-virus-associated natural killer cell-large granular lymphocyte leukaemia. Lancet 1996; 347: 1124
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Fujiwara E, Ikushima S., Todo S. Haemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. British Journal of Haematology 1994; 88: 656–658
   PubMed Web of Science ®Google Scholar
• Chen R. L., Lin K. H., Lin D. T., Su I. J., Huang L. M., Lee P. I., Hseih K. H., Lin K. S., Lee C. Y. Immunomoduiation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. British Journal of Haematology 1995; 89: 282–290
   PubMed Web of Science ®Google Scholar
• Dolezal M. V., Kamel O. W., Van de Rijn M., Cleary M. L., Sibley R. K., Wamke R. A. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. American Journal of Clinical Pathology 1995; 103: 189–194
   PubMed Web of Science ®Google Scholar
• Chen J. S., Lin K. H., Lin D. T., Chen R. L., Jou S. T., Su I. J. Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens. British Journal of Haematology 1998; 103: 756–762
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Ohara X., Iwai A., Sako M., Kato M., Arakawa H., Sotomatsu M., Kataoka S., Asami K., Hasegawa D., Kosaka Y., Sano K., Igarashi N., Maruhashi K., Ichimi R., Kawasaki H., Maeda N., Tanizawa A., Arai K., Abe T., Hisakawa H., Miyashita H., Henter J. I., For the Histiocyte Society. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869–1874
   PubMed Web of Science ®Google Scholar
• Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883–889
   PubMed Web of Science ®Google Scholar
• Henter J. I., Arico M., Egeler R. M., Elinder G., Favara B. E., Filipovich A. H., Gadner H., Imashuku S., Janka-Schaub G., Komp D., Ladisch S., Webb D. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society. Medical and Pediatric Oncology 1997; 28: 342–347
   PubMedGoogle Scholar
• Mazda O., Satoh E., Yasutomi K., Imanishi J. Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors. Journal of Immunological Methods 1997; 204: 143–151
   PubMed Web of Science ®Google Scholar
• Martin J., Sugden B. The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth and Differentiation 1991; 2: 653–660
   PubMedGoogle Scholar
• Chen M. L., Tsai C. N., Liang C. L., Shu C. H., Huang C. R., Sulitzeanu D., Liu S. T., Chang Y. S. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131–2140
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Fujiwara F., Todo S. Hyper-interleukin (IL)-6-naemia in haemophagocytic lymphohistiocytosis. British Journal of Haematology 1996; 93: 803–807
   PubMed Web of Science ®Google Scholar
• Johnson R. J., Stack M., Hazlewood S. A., Jones M., Black-More C. G., Hu L. F., Rowe M. The 30-base-pair deletion in Chinese variants of Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. Journal of Virology 1998; 72: 4038–4048
   PubMed Web of Science ®Google Scholar
• Miller W. E., Cheshire J. L., Baldwin A. S., Jr, Raab-Traub N. The NPC derived C15 LMP1 protein confers enhanced activation of NF-KB and induction of the EGFR in epithelial cells. Oncogene 1998; 16: 1869–1877
   PubMed Web of Science ®Google Scholar
• Barnes P. J., Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine 1997; 336: 1066–1071
   PubMed Web of Science ®Google Scholar
• Hayashi K., Chen W. G., Chen Y. Y., Bacchi M. M., Bacchi C. E., Alvarenga M., Abreu E. S., Chang K. L., Weiss L. M. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Human Pathology 1997; 28: 1408–1414
   PubMed Web of Science ®Google Scholar
• Berger C., McQuain C., Sullivan J. L., Nadal D., Quesen-Berry P. J., Knecht H. The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. Journal of Infectious Disease 1997; 176: 1370–1373
   PubMed Web of Science ®Google Scholar
• Itakura O., Yamada S., Narita M., Kikuta H. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996; 13: 1549–1553
   PubMed Web of Science ®Google Scholar
• Khanim F., Yao Q. Y., Niedobitek G., Sihota S., Rickinson A. B., Young L. S. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88: 3491–3501
   PubMed Web of Science ®Google Scholar